Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

News Update: Salix Pharma (NASDAQ: SLXP) Soars on Xifaxan Use Expansion Approval

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
218 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Feb 24, 2010

2/24/2010-Shares of Salix Pharmaceuticals (NASDAQ:SLXP) are trading 21.2% higher to $29.40 Wednesday after the maker of gastrointestinal disease treatments said it won the backing of a U.S. panel to expand the use of its biggest medicine, Xifaxan, over concerns from regulators that the drug wasn't tested adequately.

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more